United States Human Plasma-Derived Therapeutics Market Report 2017

December 2017 | 109 pages | ID: U869C22FD1EEN
QYResearch

Abstracts

In this report, the United States Human Plasma-Derived Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Human Plasma-Derived Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Human Plasma-Derived Therapeutics market competition by top manufacturers/players, with Human Plasma-Derived Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Alkahest
• Baxter
• CSL Behring
• Entegrion, Inc.
• Gammagard
• Grifols
• Kedrion
• Octapharma
• Prometic Life Sciences
• Sanquin
• Shire

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Albumin
• Immunoglobulin
• Clotting Factor
• Prothrombin Complex
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Research Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Human Plasma-Derived Therapeutics Market Report 2017

1 HUMAN PLASMA-DERIVED THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Human Plasma-Derived Therapeutics
1.2 Classification of Human Plasma-Derived Therapeutics by Product Category
  1.2.1 United States Human Plasma-Derived Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Human Plasma-Derived Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Albumin
  1.2.4 Immunoglobulin
  1.2.5 Clotting Factor
  1.2.6 Prothrombin Complex
  1.2.7 Others
1.3 United States Human Plasma-Derived Therapeutics Market by Application/End Users
  1.3.1 United States Human Plasma-Derived Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Research Center
1.4 United States Human Plasma-Derived Therapeutics Market by Region
  1.4.1 United States Human Plasma-Derived Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
  1.4.3 Southwest Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
  1.4.5 New England Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
  1.4.6 The South Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
  1.4.7 The Midwest Human Plasma-Derived Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Human Plasma-Derived Therapeutics (2012-2022)
  1.5.1 United States Human Plasma-Derived Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 United States Human Plasma-Derived Therapeutics Revenue and Growth Rate (2012-2022)

2 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Human Plasma-Derived Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Human Plasma-Derived Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Human Plasma-Derived Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Human Plasma-Derived Therapeutics Market Competitive Situation and Trends
  2.4.1 United States Human Plasma-Derived Therapeutics Market Concentration Rate
  2.4.2 United States Human Plasma-Derived Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Human Plasma-Derived Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Human Plasma-Derived Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Human Plasma-Derived Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Human Plasma-Derived Therapeutics Price by Region (2012-2017)

4 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Human Plasma-Derived Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Human Plasma-Derived Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Human Plasma-Derived Therapeutics Price by Type (2012-2017)
4.4 United States Human Plasma-Derived Therapeutics Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Human Plasma-Derived Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Human Plasma-Derived Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Alkahest
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Alkahest Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Baxter
  6.2.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Baxter Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 CSL Behring
  6.3.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Behring Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Entegrion, Inc.
  6.4.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Gammagard
  6.5.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Gammagard Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Grifols
  6.6.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Grifols Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Kedrion
  6.7.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Kedrion Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Octapharma
  6.8.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Octapharma Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Prometic Life Sciences
  6.9.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Sanquin
  6.10.2 Human Plasma-Derived Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Sanquin Human Plasma-Derived Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Shire

7 HUMAN PLASMA-DERIVED THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 Human Plasma-Derived Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Plasma-Derived Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Human Plasma-Derived Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Human Plasma-Derived Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HUMAN PLASMA-DERIVED THERAPEUTICS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Human Plasma-Derived Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Human Plasma-Derived Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Human Plasma-Derived Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Human Plasma-Derived Therapeutics Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Human Plasma-Derived Therapeutics
Figure United States Human Plasma-Derived Therapeutics Market Size (K Pcs) by Type (2012-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Albumin Product Picture
Figure Immunoglobulin Product Picture
Figure Clotting Factor Product Picture
Figure Prothrombin Complex Product Picture
Figure Others Product Picture
Figure United States Human Plasma-Derived Therapeutics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Human Plasma-Derived Therapeutics by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure United States Human Plasma-Derived Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Plasma-Derived Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Human Plasma-Derived Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Plasma-Derived Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Human Plasma-Derived Therapeutics Sales Share by Players/Suppliers
Figure United States Human Plasma-Derived Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Human Plasma-Derived Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Human Plasma-Derived Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Human Plasma-Derived Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Human Plasma-Derived Therapeutics Revenue Share by Players/Suppliers
Table United States Market Human Plasma-Derived Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Human Plasma-Derived Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Human Plasma-Derived Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Human Plasma-Derived Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Human Plasma-Derived Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Human Plasma-Derived Therapeutics Product Category
Table United States Human Plasma-Derived Therapeutics Sales (K Pcs) by Region (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales Share by Region (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Share by Region (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Market Share by Region in 2016
Table United States Human Plasma-Derived Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Human Plasma-Derived Therapeutics Revenue Share by Region (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Revenue Market Share by Region in 2016
Table United States Human Plasma-Derived Therapeutics Price (USD/Pcs) by Region (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales (K Pcs) by Type (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales Share by Type (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Share by Type (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Market Share by Type in 2016
Table United States Human Plasma-Derived Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Human Plasma-Derived Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Human Plasma-Derived Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Human Plasma-Derived Therapeutics by Type in 2016
Table United States Human Plasma-Derived Therapeutics Price (USD/Pcs) by Types (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales (K Pcs) by Application (2012-2017)
Table United States Human Plasma-Derived Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Market Share by Application in 2016
Table United States Human Plasma-Derived Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Human Plasma-Derived Therapeutics Sales Growth Rate by Application (2012-2017)
Table Alkahest Basic Information List
Table Alkahest Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Alkahest Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Alkahest Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Alkahest Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Baxter Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Baxter Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Baxter Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table CSL Behring Basic Information List
Table CSL Behring Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Behring Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure CSL Behring Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure CSL Behring Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Entegrion, Inc. Basic Information List
Table Entegrion, Inc. Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Entegrion, Inc. Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Entegrion, Inc. Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Entegrion, Inc. Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Gammagard Basic Information List
Table Gammagard Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Gammagard Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Gammagard Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Gammagard Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Grifols Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Grifols Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Grifols Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Grifols Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Kedrion Basic Information List
Table Kedrion Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kedrion Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Kedrion Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Kedrion Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Octapharma Basic Information List
Table Octapharma Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Octapharma Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Octapharma Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Octapharma Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Prometic Life Sciences Basic Information List
Table Prometic Life Sciences Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Prometic Life Sciences Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Prometic Life Sciences Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Prometic Life Sciences Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Sanquin Basic Information List
Table Sanquin Human Plasma-Derived Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanquin Human Plasma-Derived Therapeutics Sales Growth Rate (2012-2017)
Figure Sanquin Human Plasma-Derived Therapeutics Sales Market Share in United States (2012-2017)
Figure Sanquin Human Plasma-Derived Therapeutics Revenue Market Share in United States (2012-2017)
Table Shire Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Plasma-Derived Therapeutics
Figure Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
Figure Human Plasma-Derived Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Human Plasma-Derived Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Human Plasma-Derived Therapeutics
Table Distributors/Traders List
Figure United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Human Plasma-Derived Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Human Plasma-Derived Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Human Plasma-Derived Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources